Nephros Inc (NEPH) Stock Analysis
Verdict: HOLD
Investment score: 64/100
Analysis as of
Is Nephros Inc stock worth reviewing? The TradeMates thesis
Nephros shows explosive earnings growth (1772% YoY) and strong margins (61%), but the microcap nature and conflicting price action data demand caution.
7-factor investment score
- Valuation: 50/100 (weight 20%)
- Financial Health: 85/100 (weight 15%)
- Technical Momentum: 10/100 (weight 15%)
- Earnings Quality: 95/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Nephros Inc opportunities and risks
What speaks for NEPH
- Explosive Earnings Surprises
What speaks against NEPH
- Microcap Liquidity Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| NEPH | 28.8x | 1.8x | 23.4x | 61.1% | 6.4% | 4.8% |
| DMFG | 10.4x | 1.2x | 12.2x | 18.5% | 7.8% | 0.8% |
| BURU | n/a | n/a | n/a | 4393.4% | 871212.8% | -47.2% |
| TPCS | n/a | 1.3x | 35.9x | 18.0% | -3.4% | -10.5% |
| SCWO | n/a | 173.3x | n/a | -1093.5% | -9754.2% | -3.5% |
| CLIR | n/a | 5.5x | n/a | 27.2% | -105.0% | -16.6% |
| Peer median | n/a | 1.3x | n/a | 18.5% | -3.4% | -10.5% |
Frequently asked questions about Nephros Inc (NEPH)
Is NEPH stock a good investment?
The TradeMates model rates Nephros Inc as HOLD with an investment score of 64/100. Nephros shows explosive earnings growth (1772% YoY) and strong margins (61%), but the microcap nature and conflicting price action data demand caution. This is algorithmic model output, not personal investment advice.
Is NEPH stock a buy?
The TradeMates model verdict for NEPH is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.